Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 8, 2006, Pages 1033-1039

  Boelter, M C ^a   Gross, J L ^a   Canani, L H ^a   Costa, L A ^a   Lisboa, H R ^b   Tres G S ^b   Lavinsky, J ^a   Azevedo, Mirela J ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF PASSO FUNDO   (Brazil)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Microalbuminuria; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN SENSITIVITY; KAPPA STATISTICS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; RANK SUM TEST; STUDENT T TEST; TURBIDIMETRY; URINALYSIS; URINARY EXCRETION;

EID: 33747370050     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000800006     Document Type: Article

References (23)

1. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL III, et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-156.
2. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care 2003; 26: 320-326.
3. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156-163.
4. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-419.
5. Cignarelli M, De Cicco ML, Damato A, Paternostro A, Pagliarini S, Santoro S, et al. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992; 15: 1002-1008.
6. Warpeha KM, Chakravarthy U. Molecular genetics of microvascular disease in diabetic retinopathy. Eye 2003; 17: 305-311.
7. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996; 19: 1243-1248.
8. Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997; 314: 783-788.
9. Parving HH, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988; 296:156-160.
10. Wirta O, Pasternack A, Mustonen J, Laippala P, Lahde Y. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999; 51: 329-334.
11. Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993; 100: 862-867.
12. Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes. Diabetes Care 1998; 21: 530-534.
13. Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis. J Diabetes Complications 2001; 15: 24-33.
14. Diabetic Retinopathy Study Research Group. Report VII: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981; 21: 210-226.
15. American Academy of Ophthalmology. http://www.aao.org/education/library/recommendations/upload/ Diabotic-Retinopathy-Disease-Severity-Scale.pdf; 2006.
16. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164-176.
17. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226.
18. Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003; 121: 245-251.
19. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
20. United Kingdom Prospective Diabetes Study Group. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes 1995; 44: 1249-1258.
21. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
22. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 2004; 21: 252-255.
23. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1997; 157: 650-656.